CellSight Technologies offers molecular imaging products and services to monitor survival, status, quantity and trafficking of therapeutic cells as well as the location(s) and magnitude of therapeutic gene expression to predict efficacy and potential adverse effects in cell and gene therapy. In addition, we provide services to monitor effect of drugs on cells and transplanted tissue.
Our patented imaging technology and expert molecular imaging services allows use of multiple imaging strategies in living subjects at multiple time points to enable our customers to cost effectively move their therapeutics from pre-clinical stage to clinical applications.
This video illustrates PET reporter gene based imaging of therapeutic cells in the brain of a glioma patient. The PET image is superimposed over the brain MRI, showing the location and intensity of the PET reporter imaging probe [18F]FHBG before and after injection of HSV1-tk expressing cytolytic T cells.